Sugi Predict

Sugi Predict / Compounds / SCHEMBL5091925

SCHEMBL5091925

SCHEMBL5091925

COc1cc2c(Oc3ccc(NC(=O)NCCC(C)(C)C)c(Cl)c3)ccnc2cc1O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 15/20 0.59
▸ PDGFRA P16234 11/20 0.57
▸ FLT1 P17948 4/20 0.57
▸ FLT4 P35916 4/20 0.57
▸ KIT P10721 4/20 0.57
▸ MET P08581 4/20 0.57
▸ RET P07949 3/20 0.57
▸ RIPK2 O43353 2/20 0.57
▸ STK10 O94804 2/20 0.57
▸ ABL1 P00519 2/20 0.57
▸ PDGFRB P09619 2/20 0.57
▸ BCR P11274 2/20 0.57
▸ FGFR1 P11362 2/20 0.57
▸ SLC6A3 Q01959 2/20 0.57
▸ DDR1 Q08345 2/20 0.57
▸ MAP4K2 Q12851 2/20 0.57
▸ PTK6 Q13882 2/20 0.57
▸ DDR2 Q16832 2/20 0.57
▸ AURKB Q96GD4 2/20 0.57
▸ RIPK3 Q9Y572 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4472865 0.94 KDR (0.67) KDRPDGFRAFLT1FLT4KIT
Hydrochloric Acid SCHEMBL5088438 0.93 KDR (0.66) KDRPDGFRAFLT1FLT4KIT
SCHEMBL5202425 0.91 KDR (0.67) KDRPDGFRAFLT1FLT4KIT
SCHEMBL4475247 0.90 PDGFRA (0.64) KDRPDGFRAKITMETFGFR2
SCHEMBL4464446 0.89 KDR (0.60) KDRPDGFRAFLT1FLT4KIT
SCHEMBL4470302 0.89 KDR (0.60) KDRPDGFRAFLT1FLT4KIT
SCHEMBL4469910 0.89 KDR (0.60) KDRPDGFRAFLT1FLT4KIT
SCHEMBL4476678 0.88 KDR (0.59) KDRPDGFRAFLT1FLT4KIT
SCHEMBL4471459 0.86 KDR (0.58) KDRPDGFRAFLT1FLT4KIT
SCHEMBL4480737 0.86 KDR (0.60) KDRPDGFRAFLT1FLT4KIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080207617-A1 Quinoline Derivatives and Quinazoline Derivatives Inhibiting Autophosphrylation of Flt3 and Medicinal Compositions Containing the Same KIRIN BEER KABUSHIKI KAISHA (JP) 2008-08-28 — — US disclosed
US-20080207617-A1 Quinoline Derivatives and Quinazoline Derivatives Inhibiting Autophosphrylation of Flt3 and Medicinal Compositions Containing the Same KIRIN BEER KABUSHIKI KAISHA (JP) 2008-08-28 — — US disclosed
US-20080207617-A1 Quinoline Derivatives and Quinazoline Derivatives Inhibiting Autophosphrylation of Flt3 and Medicinal Compositions Containing the Same KIRIN BEER KABUSHIKI KAISHA (JP) 2008-08-28 — — US disclosed
EP-1566379-A1 QUINOLINE DERIVATIVES AND QUINAZOLINE DERIVATIVES INHIBITING AUTOPHOSPHORYLATION OF Flt3 AND MEDICINAL COMPOSITIONS CONTAINING THE SAME KIRIN BEER KABUSHIKI KAISHA (JP) 2005-08-24 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207617-A1 Quinoline Derivatives and Quinazoline Derivatives Inhibiting Autophosphrylation of Flt3 and Medicinal Compositions Containing the Same FLT3, TYRO3, ABL1 KDR 148/4885PDGFRA 229/4885FLT1 34/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.